What is Big Think?  

We are Big Idea Hunters…

We live in a time of information abundance, which far too many of us see as information overload. With the sum total of human knowledge, past and present, at our fingertips, we’re faced with a crisis of attention: which ideas should we engage with, and why? Big Think is an evolving roadmap to the best thinking on the planet — the ideas that can help you think flexibly and act decisively in a multivariate world.

A word about Big Ideas and Themes — The architecture of Big Think

Big ideas are lenses for envisioning the future. Every article and video on bigthink.com and on our learning platforms is based on an emerging “big idea” that is significant, widely relevant, and actionable. We’re sifting the noise for the questions and insights that have the power to change all of our lives, for decades to come. For example, reverse-engineering is a big idea in that the concept is increasingly useful across multiple disciplines, from education to nanotechnology.

Themes are the seven broad umbrellas under which we organize the hundreds of big ideas that populate Big Think. They include New World Order, Earth and Beyond, 21st Century Living, Going Mental, Extreme Biology, Power and Influence, and Inventing the Future.

Big Think Features:

12,000+ Expert Videos


Browse videos featuring experts across a wide range of disciplines, from personal health to business leadership to neuroscience.

Watch videos

World Renowned Bloggers


Big Think’s contributors offer expert analysis of the big ideas behind the news.

Go to blogs

Big Think Edge


Big Think’s Edge learning platform for career mentorship and professional development provides engaging and actionable courses delivered by the people who are shaping our future.

Find out more

WHO CONTROLS STEM CELL RESEARCH? Patent Dispute Between Wisconsin and California Could Potentially Stall Research

June 18, 2006, 4:58 PM
It's rare in media coverage to see a focus on the PATENTS/PROPERTY RIGHTS dimension of stem cell research, even though patents are the engine driving research. But this weekend, the Wisconsin State Journal spotlights a developing dispute between the Wisconsin Alumni Research Foundation (WARF) and the California Institute for Regenerative Medicine (CIRM). At issue is CIRM's ability to require that 25% of all earnings from grant-supported research be given back to the state of California. The problem is that WARF, which holds the patents on most stem cell research in the United States, wants its share, and is challenging the CIRM decision.

The focus on patent disputes does not bode well for the public image of stem cell research since it interjects a second potentially negative interpretation into the debate, in this case a focus on PUBLIC ACCOUNTABILITY: Are scientists looking out for the public's interest in how they spend state money, or are they looking out for their own and/or private interests? It's an interpretation that is tailor made for the courts, and it also resonates with journalistic instincts to hold public officials accountable, even if in this case, public officials are scientists.

Here is how the Wisconsin State Journal describes the PUBLIC ACCOUNTABILITY angle:

The Foundation for Taxpayer and Consumer Rights, a nonprofit watchdog group in California, called on CIRM to challenge WARF's patents in court. "It would truly be a shame if a research organization in Wisconsin threw up a blockade to vital, publicly funded research in California," John Simpson, stem-cell project director for the group, wrote in a letter to WARF.


Newsletter: Share: